Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease annotation

Br J Haematol. 2000 Jun;109(4):699-703. doi: 10.1046/j.1365-2141.2000.02185.x.
No abstract available

MeSH terms

  • Antibodies, Antiphospholipid / blood
  • Anticoagulants / therapeutic use
  • Biomarkers / blood
  • Factor V / analysis
  • Factor V / genetics
  • Heparin / therapeutic use
  • Humans
  • International Normalized Ratio
  • Mutation
  • Predictive Value of Tests
  • Protein C / analysis
  • Protein S / analysis
  • Prothrombin / analysis
  • Prothrombin / genetics
  • Thrombophilia / diagnosis*
  • Thrombophilia / genetics*
  • Venous Thrombosis / diagnosis*
  • Venous Thrombosis / drug therapy*
  • Warfarin / therapeutic use

Substances

  • Antibodies, Antiphospholipid
  • Anticoagulants
  • Biomarkers
  • Protein C
  • Protein S
  • factor V Leiden
  • Warfarin
  • Factor V
  • Prothrombin
  • Heparin